ACCRETION PHARMA LIMITED share price
NSE: ACCPL · ISIN INE0T8T01010
Key numbers
- Market cap
- ₹ 215 Cr
- Current price
- ₹ 193.15
- 52-week high / low
- ₹ 195 / 193
- Stock P/E
- 22.2
- Book value
- ₹ 49.2
- Dividend yield
- 0.00%
- ROCE
- 28.9%
- ROE
- 27.6%
- Debt to equity
- 0.23
- Sales growth (3 yrs)
- -
- Profit growth (3 yrs)
- -
- 1-year return
- -
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|
| Sales | 39 | 44 | 46 |
| Operating profit | 8 | 7 | 8 |
| Net profit | 4 | 5 | 5 |
| EPS (₹) | 5.30 | 4.61 | 4.42 |
Investor presentation summary (2026-05-15)
AI summary of the presentation · tone: Positive · source document
Key numbers
- 16.17%(226 bps)19.43%17.17%EBITDA Margin* (%)
- 10.87%(44 bps)11.15%10.71%Profit After Tax Margin%
Guidance & outlook
- H1 FY26YoY%H2 FY25H2 FY26Particulars (Rs. in Crore)
- FY22FY23FY24FY25FY26Particulars (Rs. in Crore)
Growth & demand
- 56.21% YoY growth in Revenues FY26
- Rs. 2,26,000 Cr, growth in
Margins & costs
- growth, healthy margins, and robust returns,
- India's CDMO services offer ~20% lower costs than China, making the
Capex & expansion
- Capacity and Capacity Utilization (In Crore)
- Capacity and Capacity Utilization(In Crores)
Peers in Pharmaceuticals
Data for information only, not investment advice. Prices end of day.